# Cytokinetics Inc: filings

CYTK · Nasdaq · CIK 1061983 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cytk.md) · [Financials](/companies/cytk/financials.md) · [Filings](/companies/cytk/filings.md) · [Insiders](/companies/cytk/insiders.md)

## Reports and events: 530 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1081, 8-K 432, 144 136, SC 13G/A 95, 10-Q 53, 3 30, 424B5 27, SC 13G 25, CT ORDER 19, 10-K 18, DEF 14A 18, S-8 17, UPLOAD 14, CORRESP 12, SCHEDULE 13G/A 10, 4/A 8, DEFA14A 7, 8-K/A 6, EFFECT 6, S-3 6, PRE 14A 5, ARS 4, S-3ASR 4, 10-Q/A 3, 3/A 3, 5 2, FWP 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 305B2 1, 424B3 1, S-3MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-28 | 13:21 ET | [8-K](/filings/0001193125-26-372456.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-372456 |
| 2026-08-13 | 13:25 ET | [8-K](/filings/0001193125-26-348060.md) | 8.01 Other events | 0001193125-26-348060 |
| 2026-08-06 | 20:30 ET | [10-Q](/filings/0001193125-26-338217.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338217 |
| 2026-08-06 | 20:11 ET | [8-K](/filings/0001193125-26-338021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-338021 |
| 2026-05-27 | 20:00 ET | [8-K](/filings/0001193125-26-241840.md) | 5.07 Shareholder vote results | 0001193125-26-241840 |
| 2026-05-08 | 20:05 ET | [8-K](/filings/0001193125-26-214606.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-214606 |
| 2026-05-05 | 20:12 ET | [8-K](/filings/0001193125-26-206420.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-206420 |
| 2026-05-05 | 20:06 ET | [10-Q](/filings/0001193125-26-206364.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206364 |
| 2026-05-05 | 20:05 ET | [8-K](/filings/0001193125-26-206360.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206360 |
| 2026-04-17 | 20:05 ET | [DEF 14A](/filings/0001140361-26-015364.md) | Proxy statement, period 2026-05-27 | 0001140361-26-015364 |
| 2026-02-26 | 21:01 ET | [10-K](/filings/0001193125-26-076495.md) | Annual report, period 2025-12-31 | 0001193125-26-076495 |
| 2026-02-24 | 21:13 ET | [8-K](/filings/0001193125-26-067012.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-067012 |
| 2026-02-17 | 12:30 ET | [8-K](/filings/0001193125-26-053049.md) | 8.01 Other events | 0001193125-26-053049 |
| 2025-12-19 | 21:01 ET | [8-K](/filings/0001193125-25-326778.md) | 8.01 Other events | 0001193125-25-326778 |
| 2025-12-12 | 13:54 ET | [8-K](/filings/0001193125-25-316904.md) | 8.01 Other events | 0001193125-25-316904 |
| 2025-11-14 | 21:05 ET | [8-K](/filings/0001193125-25-282889.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-282889 |
| 2025-11-05 | 21:31 ET | [10-Q](/filings/0001193125-25-267059.md) | Quarterly report, period 2025-09-30 | 0001193125-25-267059 |
| 2025-11-05 | 21:00 ET | [8-K](/filings/0001193125-25-266842.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266842 |
| 2025-09-22 | 23:22 ET | [8-K](/filings/0001193125-25-209437.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-209437 |
| 2025-09-16 | 20:08 ET | [8-K](/filings/0001193125-25-204991.md) | 8.01 Other events | 0001193125-25-204991 |
| 2025-09-08 | 21:02 ET | [8-K/A](/filings/0000950170-25-113599.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-113599 |
| 2025-09-03 | 21:34 ET | [8-K](/filings/0000950170-25-112570.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112570 |
| 2025-09-02 | 21:20 ET | [8-K](/filings/0000950170-25-112564.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112564 |
| 2025-08-20 | 11:57 ET | [8-K](/filings/0000950170-25-110368.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-110368 |
| 2025-08-07 | 20:30 ET | [10-Q](/filings/0000950170-25-105108.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105108 |
| 2025-08-07 | 20:01 ET | [8-K](/filings/0000950170-25-104962.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104962 |
| 2025-05-16 | 22:39 ET | [8-K](/filings/0000950170-25-072965.md) | 5.07 Shareholder vote results | 0000950170-25-072965 |
| 2025-05-06 | 20:30 ET | [10-Q](/filings/0000950170-25-064529.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064529 |
| 2025-05-06 | 20:05 ET | [8-K](/filings/0000950170-25-064432.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-064432 |
| 2025-05-01 | 20:15 ET | [8-K](/filings/0000950170-25-061847.md) | 8.01 Other events | 0000950170-25-061847 |
| 2025-04-10 | 11:30 ET | [DEF 14A](/filings/0001140361-25-013167.md) | Proxy statement, period 2025-05-14 | 0001140361-25-013167 |
| 2025-03-10 | 11:30 ET | [8-K](/filings/0000950170-25-035914.md) | 7.01 Regulation FD disclosure | 0000950170-25-035914 |
| 2025-02-27 | 22:05 ET | [10-K](/filings/0000950170-25-029206.md) | Annual report, period 2024-12-31 | 0000950170-25-029206 |
| 2025-02-27 | 21:05 ET | [8-K](/filings/0000950170-25-029017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029017 |
| 2025-02-11 | 12:30 ET | [8-K](/filings/0000950170-25-017458.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-017458 |
| 2024-12-16 | 21:38 ET | [8-K](/filings/0000950170-24-136695.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-136695 |
| 2024-11-19 | 11:02 ET | [8-K](/filings/0000950170-24-128266.md) | 1.01 Entry into a material agreement | 0000950170-24-128266 |
| 2024-11-07 | 21:05 ET | [10-Q](/filings/0000950170-24-123283.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123283 |
| 2024-11-07 | 21:05 ET | [8-K](/filings/0000950170-24-123277.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-123277 |
| 2024-08-15 | 20:00 ET | [8-K](/filings/0000950170-24-097556.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-097556 |
| 2024-08-09 | 20:05 ET | [10-Q](/filings/0000950170-24-094743.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094743 |
| 2024-08-08 | 20:01 ET | [8-K](/filings/0000950170-24-093855.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093855 |
| 2024-06-07 | 21:13 ET | [8-K](/filings/0001193125-24-157531.md) | 8.01 Other events | 0001193125-24-157531 |
| 2024-06-05 | 14:02 ET | [8-K](/filings/0000950170-24-069098.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-069098 |
| 2024-05-28 | 20:01 ET | [8-K](/filings/0001193125-24-148077.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-148077 |
| 2024-05-22 | 20:15 ET | [8-K](/filings/0001193125-24-144965.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-144965 |
| 2024-05-22 | 20:13 ET | [8-K](/filings/0001193125-24-144956.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation | 0001193125-24-144956 |
| 2024-05-17 | 22:56 ET | [8-K](/filings/0000950170-24-061275.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-061275 |
| 2024-05-13 | 20:09 ET | [8-K](/filings/0000950170-24-058654.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-058654 |
| 2024-05-10 | 20:05 ET | [10-Q](/filings/0000950170-24-057805.md) | Quarterly report, period 2024-03-31 | 0000950170-24-057805 |

Page 1 of 11. [Older](/companies/cytk/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.